
Holly M. Algood, Ph.D.
- Assistant Professor of Medicine (Infectious Diseases)
- Assistant Professor Pathology, Microbiology and Immunology
- Research Microbiologist
Holly M. Algood, Ph.D.
- Assistant Professor of Medicine (Infectious Diseases)
- Assistant Professor Pathology, Microbiology and Immunology
- Research Microbiologist
615-343-9242
holly.m.algood@vumc.org
Nashville, TN 37232
Research Program
Departments/Affiliations
Profile
H. pylori is the most common pathogen colonizing humans today. Colonization with H. pylori can lead to detrimental outcomes including gastric adenocarcinoma, MALT lymphoma, peptic ulcer disease and atrophic gastritis. H. pylori is the only bacteria classified by the World Health Organization as a carcinogen. Yet, H. pylori’s classification as a bone fide pathogen has been questioned due to an inverse correlation between H. pylori colonization and immune-mediated diseases, such as allergic airway disease and inflammatory bowel disease. These divergent outcomes can be attributed to a number of factors including host, environment and pathogen.
My laboratory has made noteworthy contributions to understanding which host factors drive gastritis during chronic H. pylori infection. Specifically, our research has described how cytokines produced by proinflammatory T cells influence control of H. pylori colonization and gastritis. A major role of these T cells and the cytokines they produce is to recruit innate immune cells which lead to increased inflammation. Some stresses of the immune response include sequestration of nutrient metals (nutritional immunity), oxidative stress and metabolic stress. Despite the chronic immune response, H. pylori persists for the life of the host. A fundamental gap in our knowledge is how H. pylori responds to and flourishes under the pressures of the host’s immune response and how diet modifications might alter those host responses.
Education
- Mount Union College (Alliance, OH), Bachelors of Science, May 1998
- University of Pittsburgh:(Pittsburgh, PA), Doctor of Philosophy, (Molecular Virology and Microbiology Program in the School of Medicine), December 2003
- Vanderbilt University (Nashville, TN), Post-doctoral Fellow, June 2004- March 2008
Research Emphasis
Helicobacter pylori, inflammation, T lymphocytes, cytokines, bacterial pathogenesis, Th17, bacterial response, oxidative stress, host-pathogen interactions, macrophages, cancer
Research Description
Projects in Dr. Algood's lab focus on pathogen - host interactions in chronic infections and during chronic inflammation. Her main model system is Helicobacter pylori infection. Helicobacter pylori is a Gram-negative pathogen which can chronically colonize the human stomach and lead to adverse disease outcomes such as peptic ulcers or gastric cancer. Her projects investigate how T cell cytokines influence gastric epithelial cells responding to infection but also even more broadly how T cell cytokines activate other cells to protect the epithelial cells and the mucosal barrier they maintain. Dr. Algood's research utilizes H. pylori as a model mucosal pathogen, but her long-term research interests lie in understanding the balance between the mucosal immune responses, pathogens, and normal flora. While immune responses may be necessary to control bacterial colonization at the mucosal surfaces, the immune response must also be well controlled to maintain epithelial cell integrity and to control infiltration of other potentially damaging immune cells. Th17-driven immune responses have been implicated in pro-inflammatory activity and induction of chronic inflammation; she would like to better understand how the Th17 response is balanced. Moreover, since the inflammatory/immune response is not sufficient to clear the infection, Dr. Algood's laboratory is beginning studies to investigate how the bacteria persist while combated with the stresses of the immune response.
Publications
- Lin AS, Shuman JHB, Kotnala A, Shaw JA, Beckett AC, Harvey JL, Tuck M, Dixon BREA, Reyzer ML, Algood HMS, Schey KL, Piazuelo MB, Cover TL. Loss of Corpus-Specific Lipids in Helicobacter pylori-Induced Atrophic Gastritis. MSphere [print-electronic]. 2021 Nov 11/24/2021; e0082621. PMID: 34817238, PMCID: PMC8612251, DOI: 10.1128/mSphere.00826-21, ISSN: 2379-5042.
- Harvey ML, Lin AS, Sun L, Koyama T, Shuman JHB, Loh JT, Algood HMS, Scholz MB, McClain MS, Cover TL. Enhanced Fitness of a Helicobacter pylori babA Mutant in a Murine Model. Infect Immun [print-electronic]. 2021 Sep 9/16/2021; 89(10): e0072520. PMID: 34310886, PMCID: PMC8445181, DOI: 10.1128/IAI.00725-20, ISSN: 1098-5522.
- Lin AS, McClain MS, Beckett AC, Caston RR, Harvey ML, Dixon BREA, Campbell AM, Shuman JHB, Sawhney N, Delgado AG, Loh JT, Piazuelo MB, Algood HMS, Cover TL. Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis. MBio. 2020 Jun 6/30/2020; 11(3): PMID: 32605987, PMCID: PMC7327173, PII: mBio.01296-20, DOI: 10.1128/mBio.01296-20, ISSN: 2150-7511.
- Algood HMS. T Cell Cytokines Impact Epithelial Cell Responses during Helicobacter pylori Infection. J Immunol. 2020 Mar 3/15/2020; 204(6): 1421-8. PMID: 32152211, PMCID: PMC7080313, PII: 204/6/1421, DOI: 10.4049/jimmunol.1901307, ISSN: 1550-6606.
- Dixon BREA, Hossain R, Patel RV, Algood HMS. Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm. Infect Immun [electronic-print]. 2019 Nov; 87(11): PMID: 31427446, PMCID: PMC6803329, PII: IAI.00363-19, DOI: 10.1128/IAI.00363-19, ISSN: 1098-5522.
- Yasmin S, Dixon BREA, Olivares-Villagómez D, Algood HMS. Interleukin-21 (IL-21) Downregulates Dendritic Cell Cytokine Responses to Helicobacter pylori and Modulates T Lymphocyte IL-17A Expression in Peyer's Patches during Infection. Infect Immun [electronic-print]. 2019 Nov; 87(11): PMID: 31383743, PMCID: PMC6803323, PII: IAI.00237-19, DOI: 10.1128/IAI.00237-19, ISSN: 1098-5522.
- Dale BL, Pandey AK, Chen Y, Smart CD, Laroumanie F, Ao M, Xiao L, Dikalova AE, Dikalov SI, Elijovich F, Foss JD, Barbaro NR, Van Beusecum JP, Deger SM, Alsouqi A, Itani HA, Norlander AE, Alexander MR, Zhao S, Ikizler TA, Algood HMS, Madhur MS. Critical role of Interleukin 21 and T follicular helper cells in hypertension and vascular dysfunction. JCI Insight. 2019 Apr 4/23/2019; 5: PMID: 31013256, PMCID: PMC6629096, PII: 129278, DOI: 10.1172/jci.insight.129278, ISSN: 2379-3708.
- Sutton JA, Rogers LM, Dixon BREA, Kirk L, Doster R, Algood HM, Gaddy JA, Flaherty R, Manning SD, Aronoff DM. Protein kinase D mediates inflammatory responses of human placental macrophages to Group B Streptococcus. Am. J. Reprod. Immunol [print-electronic]. 2019 Mar; 81(3): e13075. PMID: 30582878, PMCID: PMC6459189, DOI: 10.1111/aji.13075, ISSN: 1600-0897.
- Piazuelo MB, Riechelmann RP, Wilson KT, Algood HMS. Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy. Curr. Top. Microbiol. Immunol. 2019; 421: 319-59. PMID: 31123895, PMCID: PMC6602908, DOI: 10.1007/978-3-030-15138-6_13, ISSN: 0070-217X.
- Beckett AC, Loh JT, Chopra A, Leary S, Lin AS, McDonnell WJ, Dixon BREA, Noto JM, Israel DA, Peek RM, Mallal S, Algood HMS, Cover TL. Helicobacter pylori genetic diversification in the Mongolian gerbil model. PeerJ. 2018; 6: e4803. PMID: 29796347, PMCID: PMC5961626, PII: 4803, DOI: 10.7717/peerj.4803, ISSN: 2167-8359.